Envista (NYSE:NVST) Reaches New 12-Month Low - Should You Sell?

Envista Holdings Co. (NYSE:NVST - Get Free Report) reached a new 52-week low on Friday . The company traded as low as $14.82 and last traded at $15.13, with a volume of 290644 shares. The stock had previously closed at $16.10.

Analyst Ratings Changes

A number of analysts recently commented on NVST shares. Morgan Stanley decreased their price objective on Envista from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Thursday, March 6th. New Street Research set a $19.00 price target on shares of Envista in a research note on Thursday, March 6th. Wells Fargo & Company set a $19.00 price objective on shares of Envista in a research report on Saturday, March 8th. Piper Sandler raised their target price on shares of Envista from $17.00 to $18.00 and gave the stock a "neutral" rating in a research report on Monday, February 3rd. Finally, UBS Group lowered their target price on shares of Envista from $23.00 to $21.00 and set a "neutral" rating for the company in a research note on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Envista presently has an average rating of "Hold" and a consensus target price of $20.18.

Envista Trading Up 11.2 %

The company has a market capitalization of $2.83 billion, a PE ratio of -2.53, a P/E/G ratio of 1.27 and a beta of 1.12. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. The business has a fifty day moving average price of $18.78 and a 200 day moving average price of $19.44.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. Analysts expect that Envista Holdings Co. will post 1 EPS for the current fiscal year.

Institutional Trading of Envista

Several large investors have recently added to or reduced their stakes in NVST. Treasurer of the State of North Carolina increased its holdings in Envista by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 75,560 shares of the company's stock worth $1,458,000 after purchasing an additional 480 shares during the last quarter. Amalgamated Bank grew its position in shares of Envista by 0.7% during the fourth quarter. Amalgamated Bank now owns 80,380 shares of the company's stock worth $1,551,000 after buying an additional 523 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Envista by 30.5% during the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company's stock worth $44,000 after buying an additional 538 shares in the last quarter. M&T Bank Corp increased its stake in shares of Envista by 4.2% in the fourth quarter. M&T Bank Corp now owns 16,621 shares of the company's stock worth $320,000 after buying an additional 676 shares during the last quarter. Finally, Assetmark Inc. raised its holdings in Envista by 2.5% in the fourth quarter. Assetmark Inc. now owns 39,624 shares of the company's stock valued at $764,000 after acquiring an additional 983 shares in the last quarter.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.